According to the government, lab marketing firms arranged with healthcare providers to steer test referrals to a South Carolina lab in exchange for kickbacks.

The paper-based card separates plasma from whole-blood samples, allowing them to be used for HIV viral load testing.

The firm's Anti-Measles Virus ELISA 2.0 (IgG) is used with dried blood spot samples to identify infections and determine patients' immune status.

The firm laid off all of its employees last month and inked agreements with top executives for part-time consulting work.

Qiagen alleges that BioMérieux infringes a European patent that protects the company's QuantiFeron interferon-gamma release assay technology for latent TB detection.

While electronic exchange of orders and results is commonplace in the commercial lab world, public health labs struggle with inconsistent levels of connectivity.

The group recently published a case-control study showing high sensitivity and specificity, with little drop in early-stage disease, compared to late-stage cancer.

NEW YORK – Precision cancer diagnostics firm Epredia said on Tuesday that it has received US Food and Drug Administration 510(k) marketing clearance for a whole-slide imaging system that is used for ...

The firm intends to use the net proceeds from the offering for working capital and other general corporate purposes.

One ACED project is focused on developing biomarkers for the early detection of ovarian cancer, with the goal of commercializing any resulting tests.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...